oral mucositis

Related by string. Oral mucositis * ORAL . orals . Oral : TULSA Okla. Oral Roberts . hear oral arguments . hears oral arguments . oral arguments / Mucositis : mucositis recommend . mucositis radiation dermatitis . pyrexia mucositis sepsis febrile . mucositis stomatitis vomiting dyspepsia * severe oral mucositis . oral mucositis debilitating . induced oral mucositis . oral mucositis OM *

Related by context. Frequent words. (Click for all words.) 73 mucositis 64 postherpetic neuralgia 60 onychomycosis 60 uveitis 59 Bronchitol 59 hyperuricemia 59 Zerenex 59 psoriasis 59 atopic dermatitis 59 myelofibrosis 58 relapsing remitting multiple sclerosis 58 lubiprostone 57 ADVEXIN 57 cutaneous T cell 57 PEG INTRON 57 vandetanib 56 Alpharadin 56 ACTEMRA 56 pivotal Phase III 56 febrile neutropenia 56 INCB# [002] 56 Dupuytren contracture 56 fidaxomicin 56 TREANDA 56 tesetaxel 56 bone metastases 55 mouth sores 55 diabetic macular edema 55 Torisel 55 investigational drug 55 Phase 2b clinical 55 Taxotere R 55 systemic lupus erythematosus SLE 55 pulmonary arterial hypertension 55 diabetic neuropathy 55 hormone refractory prostate cancer 55 Defibrotide 54 Actemra 54 tivozanib 54 diabetic nephropathy 54 gastrointestinal cancers 54 spasticity 54 neuropathic pain 54 investigational compound 54 postmenopausal osteoporosis 54 Phase 2a clinical 54 Phase III pivotal 54 hyperhidrosis 54 HspE7 54 allergic conjunctivitis 54 investigational oral 54 allergic rhinitis 54 Phase III clinical 54 ulcerative colitis 54 ERBITUX 54 VIDAZA 54 MGCD# [001] 54 RDEA# 54 HER2 positive breast cancer 54 CTCL 54 mCRC 53 carfilzomib 53 Rituximab 53 topical gel 53 Crohn disease 53 cold sores 53 satraplatin 53 pivotal Phase 53 rosacea 53 REVLIMID 53 eculizumab 53 oral formulation 53 hereditary angioedema 53 solid tumors 53 Marqibo 53 Phase III clinical trials 53 Perifosine 53 hepatocellular carcinoma HCC 53 fecal incontinence 53 Age Related Macular 53 taxane 53 FTY# 53 chronic hepatitis C. 53 adalimumab 53 chemotherapy induced 53 myelodysplastic syndromes MDS 53 HCV infection 53 Phase IIb clinical 53 Xcytrin 53 Vectibix 53 ofatumumab 53 perifosine 53 tamibarotene 53 seasonal allergic rhinitis 53 HUMIRA 53 hematological malignancies 53 chemotherapeutic agent 53 panitumumab 52 RSV infection 52 metastatic melanoma 52 NGX#

Back to home page